The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; Bayer; Lilly; Roche
The immune-profile of mismatch repair deficient (dMMR) colorectal cancers (CRCs) differs according to primary tumor sidedness.
 
Roberto Moretto
No Relationships to Disclose
 
Riccardo Giannini
No Relationships to Disclose
 
Gemma Zucchelli
No Relationships to Disclose
 
Mirella Giordano
No Relationships to Disclose
 
Filippo Pietrantonio
No Relationships to Disclose
 
Carlotta Antoniotti
No Relationships to Disclose
 
Clara Ugolini
No Relationships to Disclose
 
Federica Morano
No Relationships to Disclose
 
Federica Marmorino
No Relationships to Disclose
 
Elisa Sensi
No Relationships to Disclose
 
Antonino Belfiore
No Relationships to Disclose
 
Daniele Rossini
No Relationships to Disclose
 
Cristiana Lupi
No Relationships to Disclose
 
Gianluca Masi
Consulting or Advisory Role - Amgen; Bayer
Research Funding - Amgen (Inst)
 
Beatrice Borelli
No Relationships to Disclose
 
Elena Ongaro
No Relationships to Disclose
 
Alessandra Boccaccino
No Relationships to Disclose
 
Alfredo Falcone
Honoraria - Celgene; Lilly; Merck; Roche; SERVIER
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Lilly; Merck; Roche; Sanofi; SERVIER
Research Funding - Amgen (Inst); Bayer (Inst); Merck (Inst); MSD (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
 
Gabriella Fontanini
No Relationships to Disclose
 
Chiara Cremolini
Honoraria - Amgen; Bayer; Roche
Consulting or Advisory Role - Bayer; Lilly; Roche
Research Funding - Merck